Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ROSUVASTATIN CALCIUM, with a corresponding US DMF Number 26781.
Remarkably, this DMF maintains an Active status since its submission on April 09, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2014, and payment made on April 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II